EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The evaluation of efficacy and tolerability of gemcitabine vs. capecitabine therapy in the second-line setting for metastatic pancreatic cancer patients with poor performance status

Abdullah Sakin, Suleyman Sahin, Muhammed Mustafa atci, Cumhur Demir, Nurgul Yasar, Caglayan Geredeli, Sener Cihan

Journal of Oncological Sciences · 2019-12 · 5 (3) · 85-89

DOI: 10.1016/j.jons.2019.08.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Oncological Sciences, 2019-12. Verfasst von Abdullah Sakin und 6 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Sakin, A., Sahin, S., atci, M. M., Demir, C., Yasar, N., Geredeli, C., & Cihan, S. (2019). The evaluation of efficacy and tolerability of gemcitabine vs. capecitabine therapy in the second-line setting for metastatic pancreatic cancer patients with poor performance status. Journal of Oncological Sciences, 5(3), 85-89. https://doi.org/10.1016/j.jons.2019.08.003

Vancouver

Sakin A, Sahin S, atci MM, Demir C, Yasar N, Geredeli C, et al. The evaluation of efficacy and tolerability of gemcitabine vs. capecitabine therapy in the second-line setting for metastatic pancreatic cancer patients with poor performance status. Journal of Oncological Sciences. 2019;5(3):85-89. doi:10.1016/j.jons.2019.08.003

BibTeX
@article{Sakin2019,
  author = {Sakin, Abdullah and Sahin, Suleyman and atci, Muhammed Mustafa and Demir, Cumhur and Yasar, Nurgul and Geredeli, Caglayan and Cihan, Sener},
  title = {The evaluation of efficacy and tolerability of gemcitabine vs. capecitabine therapy in the second-line setting for metastatic pancreatic cancer patients with poor performance status},
  journal = {Journal of Oncological Sciences},
  year = {2019},
  volume = {5},
  number = {3},
  pages = {85--89},
  doi = {10.1016/j.jons.2019.08.003}
}
Kostenlos starten →